about
Seizure control in patients with epilepsy: the physician vs. medication factorsChange in quality of life after being diagnosed with HIV: a multicenter longitudinal studyAnxiety Disorders among US Immigrants: The Role of Immigrant Background and Social-Psychological Factors.Multidimensional assessment of spirituality/religion in patients with HIV: conceptual framework and empirical refinementEpidemiology of alcohol abuse among US immigrant populationsFaith-based HIV prevention and counseling programs: findings from the Cincinnati census of religious congregationsComprehensive presurgical functional MRI language evaluation in adult patients with epilepsy.Spirituality and religion among HIV-infected individuals.Social determinants of health in epilepsy.Alcohol use/abuse and help-seeking among U.S. adults: The role of racial-ethnic origin and foreign-born status.Social correlates of health status, quality of life, and mood states in patients treated with cannabidiol for epilepsy.Major Depressive Disorder and Dysthymia at the Intersection of Nativity and Racial-Ethnic Origins.Social factors in marijuana use for medical and recreational purposes.Family effects on self-reported health among Russian wives and husbands.Personalities of patients with nonepileptic psychogenic status.Seizure disorders, depression, and health-related quality of life.Levetiracetam use in critically ill patients.Spirituality and religiosity in patients with HIV: a test and expansion of a model.Quality of life in medication-resistant epilepsy: the effects of patient's age, age at seizure onset, and disease duration.Quality of life in psychogenic nonepileptic seizures.GENDER, SELF-REPORTED HEALTH, AND HEALTH-RELATED LIFESTYLES IN POLAND
P50
Q33394383-BF063B18-CF52-4057-84EC-528D58D0F87FQ33705691-8108AC53-D8E7-44E0-9000-72D7AD670841Q33848843-24502697-2844-4452-8BE0-91FC0E2C2898Q34899812-F09D0E8D-F62E-4AE4-AFBF-FCB22FEF028FQ35097913-B126D52E-8916-4EFD-97EB-7DB87F7C18C3Q36927991-45D40945-D15F-41B4-B66C-3232DDA4F435Q37390964-74D94BF9-553C-4AD7-ADF2-8553CAC66512Q37635845-B7B3A7D2-5A22-4DD2-AAE1-31AC9CA9223EQ38226677-A12C8886-8A67-45CB-B0A0-0135D7528738Q38692958-F25FA4FA-29A9-4F79-BDDE-32A5C3F53EA8Q38942690-C3ABCCF9-6C5A-44B6-95F4-2C87FE302561Q38956456-F4019343-76BD-45B5-B29C-6B568B46E114Q39108336-19B6E3FD-C2BB-42C2-B454-44FDA21B4E5FQ39588831-CC304393-2963-4D07-A6DA-6A34E73B7735Q41298223-79A37E4C-8794-4C32-A03A-C6F529ECB1D5Q47233222-03832582-C0B4-4C4B-8D85-E04E315E2E5FQ48118239-6A194A80-1258-4E3A-B921-9D037B8D6D0CQ48748053-450C4F06-AA9E-4FAD-AD19-8D09564F9E56Q50946086-1B7782F9-3FEC-4C3E-98A4-A492B2DEBF9DQ53398858-1A440A69-D441-441A-A60D-E2CA7B885C1AQ60739323-45953CA1-14B6-459E-842A-DF420DA6462E
P50
description
hulumtuese
@sq
researcher
@en
ricercatrice
@it
wetenschapper
@nl
հետազոտող
@hy
name
Magdalena Szaflarski
@ast
Magdalena Szaflarski
@en
Magdalena Szaflarski
@es
Magdalena Szaflarski
@nl
Magdalena Szaflarski
@sl
type
label
Magdalena Szaflarski
@ast
Magdalena Szaflarski
@en
Magdalena Szaflarski
@es
Magdalena Szaflarski
@nl
Magdalena Szaflarski
@sl
prefLabel
Magdalena Szaflarski
@ast
Magdalena Szaflarski
@en
Magdalena Szaflarski
@es
Magdalena Szaflarski
@nl
Magdalena Szaflarski
@sl
P106
P1153
6602336510
P21
P214
103152682591823312892
P31
P496
0000-0002-6228-1405
P735
P7859
viaf-103152682591823312892